The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
The INK4a/ARF locus and melanoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674 · cited 1×
“On the genetic level, the signature events in melanoma include activation of the Ras/Raf pathway (Davies et al., 2002; Herlyn and Satyamoorthy, 1996) and loss of INK4a/ARF locus function (Flores et al., 1996; Walker et al., 1998).”
BackgroundOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“…including passage in culture, growth at high density, DNA damage, oncogene activation, and advancing age (Alcorta et al., 1996; Reznikoff et al., 1996; Serrano et al., 1997; Robles and Adami, 1998; Shapiro et al., 1998; Zindy et al., 1998; Pavey et al., 1999; Wieser et al., 1999; Piepkorna, 2000).”
BackgroundA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 1×
“Figure 2 depicts the INK4a/ARF locus and open reading frames of derivative proteins, p16INK4a and p14ARF. p16INK4a was identified initially as a CDK4-associated protein capable of inhibiting CDK4/6-mediated phosphorylation of the retinoblastoma tumor suppressor protein (pRb) (Serrano et al., 1993).”
BackgroundA cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751 · cited 2×
“Germline point mutations of p16INK4a were noted to cosegregate with tumor susceptibility in kindreds with familial melanoma (Hussussian et al., 1994; Kamb et al., 1994b; Holland et al., 1995; Liu et al., 1995; Walker *Correspondence: L Chin, Department of Dermatology, Harvard Medical School, 44…”
BackgroundZhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · cited 3×
“…strengthened biochemically through a number of approaches by the demonstration that ARF binds MDM2 and inhibits the ubiquitination of p53, thereby stabilizing this archetypal tumor suppressor protein (Figure 3b) (Kamijo et al., 1998; Pomerantz et al., 1998; Stott et al., 1998; Zhang et al., 1998b).”
BackgroundSelf-citationOuelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Stott, F. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,167
A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008
Germline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966
p14ARF links the tumour suppressors RB and p53
Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., & Vousden, K. H. (1998) · Nature · doi:10.1038/25867 · Cited by 918 · cited 1×
“Several forms of oncogenic stress including expression of v-abl (Radfar et al., 1998), c-myc (Zindy et al., 1998), E1a (de Stanchina et al., 1998), or loss of Rb (Bates et al., 1998) have since been demonstrated to induce ARF and thereby stabilize p53.”
BackgroundThe p16INK4a/CDKN2A tumor suppressor and its relatives
Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8292 · Cited by 899
The pathogenesis of melanoma induced by ultraviolet radiation
Gilchrest, B. A., Eller, M. S., Geller, A. C., & Yaar, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401707 · Cited by 876 · cited 2×
“There are several nonmutually exclusive theories of UV-induced carcinogenesis; for example, UV has been suggested to act as a melanocyte mitogen (Gilchrest et al., 1999), induce the production of tumor-promoting paracrine factors (Jamal and Schneider, 2002), or attenuate antitumor immune…”
BackgroundAnalysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A. (2001) · Nature · doi:10.1038/35092592 · Cited by 848
Self-citationGermline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., Hayward, N., & Dracopoli, N. C. (1996) · Nature Genetics · doi:10.1038/ng0196-97 · Cited by 818 · cited 1×
“The importance of p16INK4a has been further reinforced by finding of alterations that target its biochemical partners, that is, CDK4 point mutation that inhibits its binding to p16INK4a (Wolfel et al., 1995; Zuo et al., 1996) or CDK6 overexpression (Tang et al., 1999).”
BackgroundCdc25 cell-cycle phosphatase as a target of c-myc
Galaktionov, K., Chen, X., & Beach, D. (1996) · Nature · doi:10.1038/382511a0 · Cited by 690
E1A signaling to p53 involves the p19ARFtumor suppressor
de Stanchina, E., McCurrach, M. E., Zindy, F., Shieh, S.-Y., Ferbeyre, G., Samuelson, A. V., Prives, C., Roussel, M. F., Sherr, C. J., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.15.2434 · Cited by 609
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A., & Berns, A. (2001) · Nature · doi:10.1038/35092584 · Cited by 568 · cited 2×
“Mice lacking p16INK4a are phenotypically normal except prone to tumors and sensitive to carcinogens (see below and Krimpenfort et al., 2001; Sharpless et al., 2001).”
BackgroundThe INK4A/ARF locus and its two gene products.
Sharpless, N. E., & DePinho, R. A. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80004-5 · Cited by 533 · cited 1×
“…locus encodes two distinct proteins, p16INK4a and p14ARF (p19ARF in the mouse), both of which demonstrate tumor suppressor activity in genetically distinct anticancer pathways (i.e. the ‘Rb pathway’ for p16INK4a and the ‘p53 pathway’ for p14ARF) (Ruas and Peters, 1998; Sharpless and DePinho, 1999).”
BackgroundSelf-citationtwist is a potential oncogene that inhibits apoptosis
Maestro, R., Tos, A. P. D., Hamamori, Y., Krasnokutsky, S., Sartorelli, V., Kedes, L., Doglioni, C., Beach, D. H., & Hannon, G. J. (1999) · Genes & Development · doi:10.1101/gad.13.17.2207 · Cited by 516
Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
Bouchard, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5321 · Cited by 502
Robles, S. J., & Adami, G. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201862 · Cited by 498
Identification of CDK4 as a target of c-MYC
Hermeking, H., Rago, C., Schuhmacher, M., Li, Q., Barrett, J. F., Obaya, A. J., O'Connell, B. C., Mateyak, M. K., Tam, W., Kohlhuber, F., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050586197 · Cited by 471
p16(MTS-1/CDKN2/INK4a) in Cancer Progression
Rocco, J. W., & Sidransky, D. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5149 · Cited by 470
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
Chin, L., Pomerantz, J., Polsky, D., Jacobson, M., Cohen, C., Cordon-Cardo, C., Horner, J. W., & DePinho, R. A. (1997) · Genes & Development · doi:10.1101/gad.11.21.2822 · Cited by 402
Self-citationNeonatal sunburn and melanoma in mice
Noonan, F. P., Recio, J. A., Takayama, H., Duray, P., Anver, M. R., Rush, W. L., De Fabo, E. C., & Merlino, G. (2001) · Nature · doi:10.1038/35095108 · Cited by 386
Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
Vlach, J., Hennecke, S., Alevizopoulos, K., Conti, D., & Amati, B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01050.x · Cited by 313
A germline deletion of p14ARF but not CDKN2A in a melanoma-neural system tumour syndrome family
Randerson-Moor, J. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.1.55 · Cited by 281
Linggi, B., Müller-Tidow, C., van de Locht, L., Hu, M., Nip, J., Serve, H., Berdel, W. E., van der Reijden, B., Quelle, D. E., Rowley, J. D., et al. (2002) · Nature Medicine · doi:10.1038/nm726 · Cited by 258
Alevizopoulos, K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5322 · Cited by 203
Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression
O'Hagan, R. C., Ohh, M., David, G., de Alboran, I. M., Alt, F. W., Kaelin, W. G., & DePinho, R. A. (2000) · Genes & Development · doi:10.1101/gad.827200 · Cited by 194
Sun exposure and melanocytic naevi in young Australian children
Harrison, S. L., Speare, R., Wronski, I., & MacLennan, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90348-4 · Cited by 191
Pollock, P. M., Pearson, J. V., & Hayward, N. K. (1996) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199602)15:2<77::aid-gcc1>3.0.co;2-0 · Cited by 189
Involvement of Myc Activity in a G1/S-Promoting Mechanism Parallel to the pRb/E2F Pathway
Santoni-Rugiu, E., Falck, J., Mailand, N., Bartek, J., & Lukas, J. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3497-3509.2000 · Cited by 172
A melanoma-associated germline mutation in exon 1β inactivates p14ARF
Rizos, H., Puig, S., Badenas, C., Malvehy, J., Darmanian, A. P., Jiménez, L., Milà, M., & Kefford, R. F. (2001) · Oncogene · doi:10.1038/sj.onc.1204728 · Cited by 171
Dual Inactivation of RB and p53 Pathways in RAS-Induced Melanomas
Bardeesy, N., Bastian, B. C., Hezel, A., Pinkel, D., DePinho, R. A., & Chin, L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2144-2153.2001 · Cited by 166
Self-citationp16 INK4A Participates in a G 1 Arrest Checkpoint in Response to DNA Damage
Shapiro, G. I., Edwards, C. D., Ewen, M. E., & Rollins, B. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.378 · Cited by 165
Invasive melanoma in Cdk4-targeted mice
Sotillo, R., García, J. F., Ortega, S., Martín, J., Dubus, P., Barbacid, M., & Malumbres, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241338598 · Cited by 164
Walker, G. J., Flores, J. F., Glendening, J. M., Lin, A. H., Markl, I. D. C., & Fountain, J. W. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199806)22:2<157::aid-gcc11>3.0.co;2-n · Cited by 161
p19 Arf induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation
Radfar, A., Unnikrishnan, I., Lee, H., DePinho, R. A., & Rosenberg, N. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13194 · Cited by 161
Zhang, S., Ramsay, E. S., & Mock, B. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2429 · Cited by 154
Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds
Walker, G. J., Hussussian, C. J., Flores, J. F., Glendening, M. J., Haluska, F. G., Dracopoli, N. C., Hayward, N. K., & Fountain, J. W. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.10.1845 · Cited by 141
Cutaneous melanoma and sunburns in childhood in a Southern European population
Zanetti, R., Franceschi, S., Rosso, S., Colonna, S., & Bidoli, E. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90480-p · Cited by 134
Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model
Kannan, K., Sharpless, N. E., Xu, J., O’Hagan, R. C., Bosenberg, M., & Chin, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336397100 · Cited by 120
Self-citationBerns, K., Hijmans, E. M., & Bernards, R. (1997) · Oncogene · doi:10.1038/sj.onc.1201280 · Cited by 115
Fåhræus, R., & Lane, D. P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2106 · Cited by 113
Schmid, M., Malicki, D. M., Nobori, T., Rosenbach, M., Campbell, K., Carson, D. A., & Carrera, C. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202205 · Cited by 107
Nairn, R. S., Kazianis, S., McEntire, B. B., Coletta, L. D., Walter, R. B., & Morizot, D. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13042 · Cited by 83
G2 phase cell cycle arrest in human skin following UV irradiation
Pavey, S., Russell, T., & Gabrielli, B. (2001) · Oncogene · doi:10.1038/sj.onc.1204707 · Cited by 80 · cited 1×
“These data do not support the view that p16INK4a plays a major role in the damage response to UV as suggested (Pavey et al., 1999; Piepkorn, 2000; Pavey et al., 2001), but rather suggest that it or other Rb-pathway components are targeted by UV.”
Resultp16INK4 mediates contact-inhibition of growth
Wieser, R. J., Faust, D., Dietrich, C., & Oesch, F. (1999) · Oncogene · doi:10.1038/sj.onc.1202270 · Cited by 77
Photocarcinogenesis in human adult skin grafts
Berking, C. (2002) · Carcinogenesis · doi:10.1093/carcin/23.1.181 · Cited by 75
Piepkorn, M. W. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.103988 · Cited by 44
Cited by
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Melanoma biology and new targeted therapy
Gray-Schopfer, V., Wellbrock, C., & Marais, R. (2007) · Nature · doi:10.1038/nature05661 · Cited by 1,371
Miller, A. J., & Mihm, M. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052166 · Cited by 1,339
Patton, E. E., Widlund, H. R., Kutok, J. L., Kopani, K. R., Amatruda, J. F., Murphey, R. D., Berghmans, S., Mayhall, E. A., Traver, D., Fletcher, C. D. M., et al. (2005) · Current Biology · doi:10.1016/j.cub.2005.01.031 · Cited by 664
Cutaneous melanoma: From pathogenesis to therapy (Review)
Leonardi, G., Falzone, L., Salemi, R., Zangh�, A., Spandidos, D., Mccubrey, J., Candido, S., & Libra, M. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4287 · Cited by 588
Metadata
- Authors
- Sharpless, N. E., & Chin, L.
- Venue
- Oncogene
- Published
- 2003-05-19
- Volume
- 22
- Issue
- 20
- Pages
- 3092-3098
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2009489886
- Cited by
- 261
- References
- 59
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.